Committed to sharing our science

Committed to sharing our science

scientist testing potential medicines

327 results available

A Phase III Trial of Tirasemtiv as a Potential Treatment for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Shefner JM, Cudkowicz, ME, Hardiman O, Cockroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff, AA, Andrews JA.
May 13, 2019
Effect of Omecamtiv Mecarbil in Patients With Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation/Flutter: Results from COSMIC-HF

Poster, American College of Cardiology (ACC) 2019
New Orleans, LA
March 2019
Correlation Between Slow Vital Capacity Measured at Home and in the Clinic for Patients With Amyotrophic Lateral Sclerosis

Poster, 29th International Symposium on ALS/MND
Glasgow, Scotland, UK
December 2018
Impact of Time Since Diagnosis on Response to Tirasemtiv, A Fast Skeletal Muscle Troponin Activator, in Patients With Amyotrophic Lateral Sclerosis: A Subgroup Analysis of VITALITY-ALS

Poster, 29th International Symposium on ALS/MND
Glasgow, Scotland, UK
December 2018
Noninvasive Ventilation Use in Patients Enrolled in VITALITY-ALS

Poster, 29th International Symposium on ALS/MND
Glasgow, Scotland, UK
December 2018